Quadrature Capital’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-14,296
Closed -$161K 1370
2025
Q4
$161K Buy
+14,296
New +$164K ﹤0.01% 1013
2024
Q3
Sell
-13,313
Closed -$266K 968
2024
Q2
$266K Sell
13,313
-299
-2% -$5.82K ﹤0.01% 862
2024
Q1
$271K Sell
13,612
-9,595
-41% -$185K ﹤0.01% 942
2023
Q4
$521K Buy
23,207
+9,320
+67% +$192K 0.01% 658
2023
Q3
$281K Buy
+13,887
New +$315K 0.01% 754
2022
Q2
Sell
-7,884
Closed -$264K 730
2022
Q1
$264K Buy
7,884
+1,379
+21% +$44.4K 0.01% 548
2021
Q4
$226K Sell
6,505
-4,227
-39% -$137K 0.01% 555
2021
Q3
$335K Buy
+10,732
New +$364K 0.01% 472
2021
Q2
Sell
-4,700
Closed -$206K 939
2021
Q1
$206K Buy
+4,700
New +$221K 0.01% 749
2016
Q4
Sell
-13,235
Closed -$459K 610
2016
Q3
$459K Buy
+13,235
New +$464K 0.04% 374

Other funds holding AVNS